KOMISJA NADZORU FINANSOWEGO
Raport bieżący nr20/2021
Data sporządzenia: 2021-12-22
Skrócona nazwa emitenta
MILESTONE MEDICAL
Temat
Signing the purchase agreement for CompuFlo Epidural / CathCheck Verification System disposables with a premier northeast teaching hospital
Podstawa prawna
Art. 17 ust. 1 MAR - informacje poufne.
Treść raportu:
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that following a successful trial, it has signed an agreement for the purchase of the CompuFlo® Epidural and CathCheck™ Verification System disposables with a major northeast teaching hospital, which is part of one of the leading health systems in the United States. The name of the hospital cannot be disclosed for confidentiality reasons. The Board of Directors of the Company is pleased to announce adoption of CompuFlo Epidural and CathCheck Verification System by yet another major hospital. This approval follows an extensive trial, which further validates the safety and efficacy of the technology. As a teaching hospital, the CompuFlo Epidural and CathCheck Verification Systems provide residents, fellows and even seasoned physicians greater accuracy through real-time verification of epidural needle placement, as well as subsequent monitoring of catheter placement. While the initial rollout is focused on the labor and delivery market, The Board of Directors of the Company is also targeting the pain management sector. The network of this major northeast teaching hospital, not only includes numerous hospitals, but also specialty centers, outpatient centers and sports medicine centers. The CompuFlo Epidural Instrument has the potential to reduce costs associated with morbidity, providing a direct economic benefit to healthcare institutions. Similarly, the CathCheck Verification System technology has the potential to transform the monitoring of catheter placement following an epidural procedure by confirming the placement of a catheter within two minutes, versus the 20 to 40 minutes using conventional methods. In the opinion of the Board of Directors of the Company, the clinical and safety benefits of the CompuFlo Epidural and CathCheck Verification Systems are backed by extensive published clinical data demonstrating reductions in epidural punctures, as well as complication rates, and contribute to savings of time on the part of anesthesiologists.
MESSAGE (ENGLISH VERSION)
MILESTONE MEDICAL INC
(pełna nazwa emitenta)
MILESTONE MEDICAL
(skrócona nazwa emitenta)(sektor wg. klasyfikacji GPW w W-wie)
NJ 07039.
(kod pocztowy)(miejscowość)
South Orange Avenue Livingston220
(ulica)(numer)
+11 973 535 2717+11 973 535 2829
(telefon)(fax)
(e-mail)(www)
27-5484393
(NIP)(REGON)
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
DataImię i NazwiskoStanowisko/FunkcjaPodpis
2021-12-22Keisha HarcumControllerKeisha Harcum